Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to 0.4%.

  • China Pharma Holdings' Return on Capital Employed rose 1100.0% to 0.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4%, marking a year-over-year increase of 1100.0%. This contributed to the annual value of 0.43% for FY2024, which is 1600.0% down from last year.
  • Per China Pharma Holdings' latest filing, its Return on Capital Employed stood at 0.4% for Q3 2025, which was up 1100.0% from 0.42% recorded in Q2 2025.
  • China Pharma Holdings' Return on Capital Employed's 5-year high stood at 0.26% during Q1 2022, with a 5-year trough of 0.83% in Q4 2022.
  • Its 5-year average for Return on Capital Employed is 0.43%, with a median of 0.4% in 2024.
  • In the last 5 years, China Pharma Holdings' Return on Capital Employed surged by 15700bps in 2021 and then tumbled by -5500bps in 2022.
  • China Pharma Holdings' Return on Capital Employed (Quarter) stood at 0.29% in 2021, then crashed by -189bps to 0.83% in 2022, then soared by 64bps to 0.3% in 2023, then tumbled by -65bps to 0.5% in 2024, then grew by 21bps to 0.4% in 2025.
  • Its last three reported values are 0.4% in Q3 2025, 0.42% for Q2 2025, and 0.47% during Q1 2025.